Cargando…

Performance of International AIDS Vaccine Initiative African clinical research laboratories in standardised ELISpot and peripheral blood mononuclear cell processing in support of HIV vaccine clinical trials

BACKGROUND: Standardisation of procedures for performing cellular functional assays across laboratories participating in multicentre clinical trials is key for generating comparable and reliable data. OBJECTIVE: This article describes the performance of accredited laboratories in Africa and Europe o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Langat, Robert K., Farah, Bashir, Indangasi, Jackton, Ogola, Simon, Omosa-Manyonyi, Gloria, Anzala, Omu, Bizimana, Jean, Tekirya, Emmanuel, Ngetsa, Caroline, Silwamba, Moses, Muyanja, Enoch, Chetty, Paramesh, Jangano, Maureen, Hills, Nancy, Gilmour, Jill, Dally, Len, Cox, Josephine H., Hayes, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AOSIS 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014752/ https://www.ncbi.nlm.nih.gov/pubmed/33833946 http://dx.doi.org/10.4102/ajlm.v10i1.1056

Ejemplares similares

Broad HIV-1 inhibition in vitro by vaccine-elicited CD8(+) T cells in African adults
por: Mutua, Gaudensia, et al.
Publicado: (2016)

First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus–Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost Regimens
por: Nyombayire, Julien, et al.
Publicado: (2017)

Safety and Immunogenicity Study of Multiclade HIV-1 Adenoviral Vector Vaccine Alone or as Boost following a Multiclade HIV-1 DNA Vaccine in Africa
por: Jaoko, Walter, et al.
Publicado: (2010)

Uptake and tolerability of repeated mucosal specimen collection in two Phase 1 AIDS preventive vaccine trials in Kenya
por: Mutua, G, et al.
Publicado: (2012)

Reasons for Ineligibility in Phase 1 and 2A HIV Vaccine Clinical Trials at Kenya Aids Vaccine Initiative (KAVI), Kenya
por: Omosa-Manyonyi, Gloria S., et al.
Publicado: (2011)

Cultured enzyme-linked immunospot assay (ELISPOT) enhances detection of low HIV-specific immune responses in exposed seronegative individuals in Kenya
por: Muturi, Margaret, et al.
Publicado: (2006)

Acceptability and Feasibility of Repeated Mucosal Specimen Collection in Clinical Trial Participants in Kenya
por: Omosa-Manyonyi, Gloria, et al.
Publicado: (2014)

Willingness to participate in future HIV vaccine trials among men who have sex with men and female sex workers living in Nairobi, Kenya
por: Mutisya, Elizabeth Mueni, et al.
Publicado: (2020)

Modified ELISPOT: Modifications of the Elispot Assay for T Cell Monitoring in Cancer Vaccine Trials
por: Malyguine, Anatoli
Publicado: (2005)

Reported willingness to participate in a hypothetical HIV vaccine trial and its translation to actual participation among healthy adults—Experience from Kenya
por: Nyasani, Delvin Kwamboka, et al.
Publicado: (2018)

Acceptability and tolerability of repeated intramuscular electroporation of Multi-antigenic HIV (HIVMAG) DNA vaccine among healthy African participants in a phase 1 randomized controlled trial
por: Mpendo, Juliet, et al.
Publicado: (2020)

Systematic review of the performance and clinical utility of point of care HIV-1 RNA testing for diagnosis and care
por: Agutu, Clara A., et al.
Publicado: (2019)

Hepatitis B Virus Incidence and Risk Factors Among Human Immunodeficiency Virus-1 Negative Men Who Have Sex With Men in Kenya
por: Wahome, Elizabeth, et al.
Publicado: (2016)

A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African Adults
por: Mpendo, Juliet, et al.
Publicado: (2015)

Baseline Morbidity in 2,990 Adult African Volunteers Recruited to Characterize Laboratory Reference Intervals for Future HIV Vaccine Clinical Trials
por: Stevens, Wendy, et al.
Publicado: (2008)

ELISPOT Assay for Monitoring Cytotoxic T Lymphocytes (CTL) Activity in Cancer Vaccine Clinical Trials
por: Malyguine, Anatoli M., et al.
Publicado: (2012)

Using a multimethod approach to develop implementation strategies for a cervical self-sampling program in Kenya
por: Podolak, Irene, et al.
Publicado: (2017)

Assessment of hepatitis B vaccination status and hepatitis B surface antibody titres among health care workers in selected public health hospitals in Kenya
por: Mwangi, Irene Ann, et al.
Publicado: (2023)

A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults
por: Omosa-Manyonyi, Gloria, et al.
Publicado: (2015)

Safety and Adherence to Intermittent Pre-Exposure Prophylaxis (PrEP) for HIV-1 in African Men Who Have Sex with Men and Female Sex Workers
por: Mutua, Gaudensia, et al.
Publicado: (2012)

Volunteer motivators for participating in HIV vaccine clinical trials in Nairobi, Kenya
por: Nyaoke, Borna A., et al.
Publicado: (2017)

Safety and Immunogenicity of a 2-Dose Heterologous Vaccine Regimen With Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: 12-Month Data From a Phase 1 Randomized Clinical Trial in Nairobi, Kenya
por: Mutua, Gaudensia, et al.
Publicado: (2019)

Establishment of an ELISpot Assay to Detect Cellular Immunity against S. pneumoniae in Vaccinated Kidney Transplant Recipients
por: Gäckler, Anja, et al.
Publicado: (2021)

Cohort Profile: IAVI’s HIV epidemiology and early infection cohort studies in Africa to support vaccine discovery
por: Price, Matt A, et al.
Publicado: (2020)

Cryopreservation-related loss of antigen-specific IFNγ producing CD4(+) T-cells can skew immunogenicity data in vaccine trials: Lessons from a malaria vaccine trial substudy
por: Ford, Tom, et al.
Publicado: (2017)

Use of ELISpot assay to study HBs-specific B cell responses in vaccinated and HBV infected humans
por: Tian, Chen, et al.
Publicado: (2018)

Persistent immunity after therapeutic vaccination targeting HER2/neu correlated with post-vaccination magnitude of interferon gamma Elispot responses
por: Liao, John B, et al.
Publicado: (2014)

An infected chicken kidney cell co-culture ELISpot for enhanced detection of T cell responses to avian influenza and vaccination
por: Ruiz-Hernandez, Raul, et al.
Publicado: (2015)

Attitudes Toward Gender-Based Violence Among Sexually Active Adult Men at High Risk for HIV in Rustenburg, South Africa
por: Makkan, Heeran, et al.
Publicado: (2022)

Equivalence of ELISpot Assays Demonstrated between Major HIV Network Laboratories
por: Gill, Dilbinder K., et al.
Publicado: (2010)

Protocol of a randomised controlled trial characterising the immune responses induced by varicella-zoster virus (VZV) vaccination in healthy Kenyan women: setting the stage for a potential VZV-based HIV vaccine
por: Perciani, Catia T, et al.
Publicado: (2017)

Response definition criteria for ELISPOT assays revisited
por: Moodie, Z., et al.
Publicado: (2010)

Seasonal influenza vaccination in Kenya: an economic evaluation using dynamic transmission modelling
por: Dawa, Jeanette, et al.
Publicado: (2020)

Novel sporozoite-based ELISpot assay to assess frequency of parasite-specific B cells after vaccination with irradiated sporozoites
por: Atre, Tanmaya, et al.
Publicado: (2019)

P16-19. Statistical design and analysis of the CAVD-VIMC Elispot transfer study 001
por: Huang, Y, et al.
Publicado: (2009)

Hepatitis B status and associated factors among participants screened for simulated HIV vaccine efficacy trials in Kenya and Uganda
por: Mayanja, Yunia, et al.
Publicado: (2023)

Metabolic and mitochondrial dysregulation in CD4(+) T cells from HIV-positive women on combination anti-retroviral therapy
por: Akiso, Matrona, et al.
Publicado: (2023)

Acceptance of Treatment of Sexually Transmitted Infections for Stable Sexual Partners by Female Sex Workers in Kampala, Uganda
por: Mayanja, Yunia, et al.
Publicado: (2016)

Prevalence and risk factors of three curable sexually transmitted infections among women in Nairobi, Kenya
por: Maina, Anne Njeri, et al.
Publicado: (2016)

Comparing one dose of HPV vaccine in girls aged 9–14 years in Tanzania (DoRIS) with one dose of HPV vaccine in historical cohorts: an immunobridging analysis of a randomised controlled trial
por: Baisley, Kathy, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j8033722edf15pmttu9q7vkrei